These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28894181)

  • 1. Rigidly connected multispecific artificial binders with adjustable geometries.
    Wu Y; Batyuk A; Honegger A; Brandl F; Mittl PRE; Plückthun A
    Sci Rep; 2017 Sep; 7(1):11217. PubMed ID: 28894181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DARPin-Based Crystallization Chaperones Exploit Molecular Geometry as a Screening Dimension in Protein Crystallography.
    Batyuk A; Wu Y; Honegger A; Heberling MM; Plückthun A
    J Mol Biol; 2016 Apr; 428(8):1574-88. PubMed ID: 26975886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage.
    Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M
    J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rigid fusions of designed helical repeat binding proteins efficiently protect a binding surface from crystal contacts.
    Ernst P; Honegger A; van der Valk F; Ewald C; Mittl PRE; Plückthun A
    Sci Rep; 2019 Nov; 9(1):16162. PubMed ID: 31700118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DARPins: Promising Scaffolds for Theranostics.
    Shilova ON; Deyev SM
    Acta Naturae; 2019; 11(4):42-53. PubMed ID: 31993234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
    Walser M; Mayor J; Rothenberger S
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational flexibility of an anti-IL-13 DARPin†.
    Teplyakov A; Malia TJ; Obmolova G; Jacobs SA; O'Neil KT; Gilliland GL
    Protein Eng Des Sel; 2017 Jan; 30(1):31-37. PubMed ID: 27881684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module.
    Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG
    J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.
    Schilling J; Schöppe J; Plückthun A
    J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for the Selective Inhibition of c-Jun N-Terminal Kinase 1 Determined by Rigid DARPin-DARPin Fusions.
    Wu Y; Honegger A; Batyuk A; Mittl PRE; Plückthun A
    J Mol Biol; 2018 Jul; 430(14):2128-2138. PubMed ID: 29126898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs.
    Schilling J; Jost C; Ilie IM; Schnabl J; Buechi O; Eapen RS; Truffer R; Caflisch A; Forrer P
    J Biol Chem; 2022 Jan; 298(1):101403. PubMed ID: 34793836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of ordered protein assemblies using rigid three-body fusion.
    Vulovic I; Yao Q; Park YJ; Courbet A; Norris A; Busch F; Sahasrabuddhe A; Merten H; Sahtoe DD; Ueda G; Fallas JA; Weaver SJ; Hsia Y; Langan RA; Plückthun A; Wysocki VH; Veesler D; Jensen GJ; Baker D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34074752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Modeling of Designed Ankyrin Repeat Protein Complexes with Their Targets.
    Radom F; Paci E; Plückthun A
    J Mol Biol; 2019 Jul; 431(15):2852-2868. PubMed ID: 31082438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
    Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
    ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designed Ankyrin Repeat Proteins: A Look at their Evolving Use in Medicine with a Focus on the Treatment of Chorioretinal Vascular Disorders.
    Smithwick E; Stewart MW
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):33-45. PubMed ID: 28464780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-assisted structure elucidation with DARPins.
    Mittl PR; Ernst P; Plückthun A
    Curr Opin Struct Biol; 2020 Feb; 60():93-100. PubMed ID: 31918361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
    Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
    Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
    Simon M; Zangemeister-Wittke U; Plückthun A
    Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
    Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
    J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPins: a true alternative to antibodies.
    Stumpp MT; Amstutz P
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.